Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

By: Investing.com

Dec 21 2024
6
11761 Views

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations — Psyence Group Enters into Agre

TORONTO, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) hereby announces that it has entered into an addendum to the previously announced debt-for-… [+7450 chars]

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Genentech's Phase IIb Study of Prasinezumab Missed Primary Endpoint, but Suggests Possible Benefit in Early-Stage Parkinson's Disease

Europe Dental Bone Grafts And Substitutes Market to Set to Surpass Valuation of US$ 494.18 Million By 2032 | Astute Analytica

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

Major mistake people make to get yellow teeth even if they brush them twice a day

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Brokerages Set Nektar Therapeutics (NASDAQ:NKTR) Target Price at $3.50

Share this page

Guest Posts by Easy Branches

Play Blackjack & Roulette Live Dealer Casino Onlin

Introducing Grandeur: The 110m geometric superyach

The Benefits of Working with Local Residential Roo

Ferretti Group signs a supplemenary contract for 2

all our websites

Psyence Group Enters into Agreements with its NASDAQ-Listed Associate, Psyence Biomedical, to settle outstanding obligations

Related

Share this page